Mouse models for ultra-rare disorder could pave the way for nervous system gene editing therapies

Scientists at The Jackson Laboratory (JAX) have developed mouse models that survive premature death and enable pre-clinical testing of alternating hemiplegia of childhood (AHC), a devastating and sometimes fatal neurological disorder that affects about one in a million children with no current treatment.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup